This article is more than 5 years old. Information may no longer be current.
Lensar laser system gains 510(k) clearance for arcuate incisions
Click Here to Manage Email Alerts
The Lensar laser platform has received 510(k) clearance from the U.S. Food and Drug Administration for the creation of arcuate incisions during cataract surgery, according to a company news release.
The device may now be used during cataract surgery for corneal and arcuate incisions, lens fragmentation and anterior capsulotomy with or without phacofragmentation, the release said.
The platform relies on the company’s Augmented Reality technology to help provide precise and reproducible results, according to the release.
Augmented Reality uses high-resolution imaging and measurement technology to provide low-noise, high-contrast 3-D images of the anterior anatomy of the eye. It can correct for lens tilt or centration to allow for customizable treatment, according to the release.
The Lensar system also can reduce or eliminate the use of ultrasound energy in phacofragmentation.